Baylor College Of Medicine
Clinical trials sponsored by Baylor College Of Medicine, explained in plain language.
-
Can a protein infusion cut dangerous fluid buildup in liver disease?
Disease control Recruiting nowThis study tests whether giving a higher dose of albumin (a protein) to people with advanced liver cirrhosis and fluid buildup (ascites) can reduce the need for fluid drainage procedures and prevent complications. About 100 adults with hard-to-treat ascites will receive either hi…
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New study aims to help cancer patients juggle multiple health issues
Disease control Recruiting nowThis study tests a program called OPTIMISE that helps cancer patients manage other chronic conditions like diabetes or high blood pressure during treatment. It assigns a nurse navigator to improve communication between cancer doctors and primary care doctors. About 340 patients w…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Supercharged immune cells take on Hard-to-Treat lymphoma
Disease control Recruiting nowThis early-phase trial tests a new type of immune cell therapy for patients with EBV-positive Hodgkin or non-Hodgkin lymphoma that has returned or not responded to standard treatments. The researchers add a gene called C7R to the patient's own T cells to help them survive longer …
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Engineered donor cells take on lymphoma in early trial
Disease control Recruiting nowThis early-phase study tests a new approach for patients with certain lymphomas (Hodgkin, NK/T-cell, and others) that have returned or not responded to treatment. The therapy uses immune cells from healthy donors that are specially trained in the lab to attack cancer cells carryi…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Banked immune cells show promise against Life-Threatening viruses in transplant patients
Disease control Recruiting nowThis early-phase study tests whether specially trained immune cells from healthy donors can safely treat viral infections (EBV, CMV, adenovirus, BK virus) in patients who have had a stem cell transplant or certain CAR-T therapy. These infections can be life-threatening when the i…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Engineered t cells take on lymphoma in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment for people with Hodgkin or non-Hodgkin lymphoma that has returned or not responded to standard therapy. The treatment uses the patient's own T cells, which are genetically modified to recognize and attack cancer cells carrying the CD30…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Teens with prediabetes: walk 10,000 steps and skip Late-Night snacks to boost health
Disease control Recruiting nowThis study tests whether walking at least 10,000 steps a day and avoiding snacks after 8 p.m. can improve metabolic health in teenagers aged 12-18 with prediabetes. Eighty participants will be randomly assigned to either the lifestyle program or standard care for 8 weeks. The mai…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Engineered donor cells take aim at tough T-Cell cancers
Disease control Recruiting nowThis early-phase study tests a new treatment for people with T-cell leukemia or lymphoma that has come back. The treatment uses specially trained immune cells from a healthy donor, designed to recognize and attack cancer cells carrying a marker called CD7. The goal is to see if t…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could growth hormone ease gulf war illness symptoms?
Disease control Recruiting nowThis study tests whether growth hormone replacement therapy is safe and effective for veterans with Gulf War Illness who also have a growth hormone deficiency. Twenty veterans will receive the hormone for six months, and researchers will measure changes in belly fat, symptoms, an…
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Engineered t cells take on deadly brain cancers
Disease control Recruiting nowThis early-phase trial tests a new type of immune therapy for people with certain aggressive brain tumors, including DIPG and high-grade glioma. The treatment uses the patient's own T cells, which are modified in the lab to recognize a protein called GD2 on cancer cells and to pr…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Pioneering fetal surgery aims to fix birth defect before birth
Disease control Recruiting nowThis trial tests a new fetal surgery to repair complex gastroschisis, a birth defect where the baby's intestines stick out of the belly. Ten pregnant women will undergo a fetoscopic procedure to reduce the bowel and close the skin. The goal is to see if this approach is safe and …
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Supercharged donor cells take on lymphoma in early trial
Disease control Recruiting nowThis early-phase trial tests a new approach for people with certain lymphomas that have come back or not responded to treatment. Researchers take immune cells from healthy donors, modify them to recognize and attack CD30-positive cancer cells, and add a molecule (C7R) to boost th…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New hope for kids with leukemia in malawi: adapted treatment shows promise
Disease control Recruiting nowThis study looks at whether a special treatment plan for children with acute myeloid leukemia (AML) can work well in Malawi, where resources are limited. About 30 children under 18 will receive a treatment guideline designed to balance curing the disease with manageable side effe…
Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Supercharged immune cells take on childhood cancers
Disease control Recruiting nowThis early-phase trial tests a new immunotherapy called CARE T cells in children and young adults with solid tumors that have returned or not responded to standard treatment. The cells are taken from the patient, genetically modified to recognize a protein (GPC3) found on many so…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New tool aims to speed up colon polyp surgery
Disease control Recruiting nowThis study tests a new device called the Pathfinder rigidizing overtube, which stiffens during colon polyp removal to give doctors better control. Researchers will compare it to the standard procedure in 66 adults with colon growths. The goal is to see if it makes the surgery fas…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New app helps teens with diabetes focus on what they do well
Disease control Recruiting nowThis study tests a program called 'Type 1 Doing Well' for youth aged 10–13 with type 1 diabetes and their parents. The program uses a smartphone app, goal-setting, and family meetings to build on the teen's diabetes strengths. Researchers want to see if it improves blood sugar co…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New immune cells take aim at Virus-Linked lymphomas
Disease control Recruiting nowThis study tests a new way to make immune cells (called GRALE T cells) that are trained to attack cells infected with the Epstein-Barr virus (EBV), which is linked to some lymphomas. The trial includes people with Hodgkin or non-Hodgkin lymphoma, or related diseases, whose cancer…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Supercharged immune cells take aim at myeloma
Disease control Recruiting nowThis early-stage trial tests whether specially trained immune cells can safely target and attack multiple myeloma, as well as its early forms MGUS and smoldering myeloma. Up to 36 participants will receive two infusions of their own T cells that have been engineered to recognize …
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New combo attack: virus and supercharged immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests a new combination treatment for people with advanced HER2-positive solid tumors (like breast, lung, or stomach cancer). Participants receive an injection of a special virus directly into one tumor to help the immune system attack cancer, followed by a…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Genetically modified t cells take on glioblastoma
Disease control Recruiting nowThis early-stage trial tests a new type of immunotherapy for recurrent glioblastoma, an aggressive brain cancer. Researchers take a patient's own T cells and genetically engineer them to recognize and attack cancer cells that carry a protein called GPC3. The cells also include a …
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Engineered immune cells take on sarcoma in new combo trial
Disease control Recruiting nowThis study tests whether a new type of immune cell therapy (HER2-CAR T cells) combined with drugs that boost the immune system (pembrolizumab or nivolumab) is safe for people with advanced sarcoma. About 25 participants will receive chemotherapy before the cell infusion to help t…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Less invasive Stent-Graft aims to fix dangerous aortic bulges
Disease control Recruiting nowThis study is testing a special stent-graft device to repair complex aneurysms in the aorta, the body's main artery. The device is inserted through leg arteries, avoiding open surgery. Researchers will track safety, survival, and quality of life in 760 people over time. The goal …
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Supercharged immune cells take on blood cancers in new trial
Disease control Recruiting nowThis study tests a new treatment for people with advanced B-cell lymphoma or leukemia that has returned or not improved after standard therapy. Researchers take a patient's own T-cells, add a special receptor (CAR) that targets the CD19 protein on cancer cells, and also add extra…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Half-Matched stem cell transplants get safer with new Cell-Sorting technique
Disease control Recruiting nowThis study is for people who need a stem cell transplant but only have a half-matched donor, like a parent or child. Researchers are using a machine to pick out only the CD34+ stem cells from the donor's blood, removing the T cells that can cause a serious complication called gra…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New fetal procedure aims to save babies with rare bladder blockage
Disease control Recruiting nowThis study tests a step-by-step treatment plan for fetuses with lower urinary tract obstruction (LUTO), a condition where a blockage prevents urine from leaving the bladder. Doctors will use either a shunt to drain urine or a tiny scope to clear the blockage. The goal is to see i…
Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Engineered immune cells take aim at childhood leukemia
Disease control Recruiting nowThis Phase 1 trial is testing a new type of immunotherapy for children and young adults with B-cell acute lymphoblastic leukemia (B-ALL) that has come back or not gone away. The treatment uses the patient's own T cells, which are modified in the lab to recognize and attack leukem…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Supercharged immune cells take on hard-to-treat cancers
Disease control Recruiting nowThis early-phase trial tests a new type of immunotherapy for adults with solid tumors that have a protein called GPC3 on their surface. Researchers take a patient's own T cells, add genes to help them recognize and attack GPC3-positive cancer cells, and also include a safety swit…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New pacing technique could help heart failure patients live longer
Disease control Recruiting nowThis study tests a newer heart pacing method (His or left bundle branch pacing) against the standard method (biventricular pacing) in over 2,000 adults with heart failure and a weak heart pump. The goal is to see which approach better improves quality of life, reduces hospital st…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New combo therapy aims to stop mesothelioma return after surgery
Disease control Recruiting nowThis study tests whether giving immunotherapy drugs (durvalumab and tremelimumab) alone or with chemotherapy before surgery can help prevent pleural mesothelioma from coming back. About 52 people with potentially removable tumors will take part. The main goal is to see if more th…
Phase: PHASE1, PHASE2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Engineered immune cells take on childhood cancer
Disease control Recruiting nowThis early-stage trial tests a new approach for children with neuroblastoma that has come back or not responded to standard treatment. Researchers take the child's own natural killer T cells, add genes to help them recognize and attack neuroblastoma cells, and give them back alon…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 26, 2026 18:48 UTC
-
Could a single chemo drug beat the standard combo for this rare cancer?
Disease control Recruiting nowThis phase 3 trial compares two chemotherapy approaches for children and young adults with Langerhans cell histiocytosis (LCH), a rare cancer that can damage tissues. One group gets the standard two-drug combo (vinblastine/prednisone), while the other gets a single drug called cy…
Phase: PHASE3 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 26, 2026 15:37 UTC
-
Genetically modified t cells take aim at Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-phase trial is testing a new type of immunotherapy for people with T-cell leukemia or lymphoma that has returned. The treatment involves taking a patient's own immune cells (or cells from a past stem cell donor), adding a special receptor that targets a protein called …
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 26, 2026 13:32 UTC
-
AI-Powered pocket microscope could revolutionize esophageal cancer detection
Diagnosis Recruiting nowThis study tests a portable microscope with artificial intelligence to help doctors spot early signs of esophageal cancer during a routine scope exam. Researchers will enroll 200 adults in Brazil and the United States who are already scheduled for screening. The goal is to see if…
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
New study brings genetic testing to newborns in underserved texas hospitals
Diagnosis Recruiting nowThis study offers rapid whole genome sequencing and virtual genetic consultations to 200 seriously ill newborns in Texas hospitals with limited resources, especially along the Texas-Mexico border. Researchers want to see if the virtual tool, Consultagene, helps doctors diagnose r…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
Can a food prescription and parenting class help kids stay healthy?
Prevention Recruiting nowThis study tests whether combining a food prescription program with education on healthy feeding practices can help parents prevent chronic diseases like obesity in their children. Researchers will enroll 375 parents of children aged 4-8 in Texas. Participants will receive either…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Could a simple cream prevent painful UTIs in baby boys?
Prevention Recruiting nowThis pilot study tests whether applying a steroid cream to the foreskin for four weeks can prevent recurrent urinary tract infections (UTIs) in uncircumcised male infants under 6 months who have had their first fever-related UTI. Forty infants will receive either the steroid crea…
Phase: PHASE4 • Sponsor: Baylor College of Medicine • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
Phone app aims to curb diabetes in hispanic teens
Prevention Recruiting nowThis study tests a mobile health app designed to help Hispanic adolescents (ages 12-18) who are overweight improve their diet, physical activity, and sleep. The goal is to see if the app can help prevent type 2 diabetes. The study will enroll 30 participants and last 30 days, foc…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Prevention
Last updated Jun 27, 2026 09:10 UTC
-
New tool for throat surgery aims to ease swallowing trouble
Symptom relief Recruiting nowThis study looks at how safe and effective a new device, the Speedboat UltraSlim™, is when used for a surgery called POEM in people with achalasia or other throat muscle problems. The surgery is already standard care, and researchers will track symptom improvement and any side ef…
Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New 3D-Printed brace aims to make scoliosis treatment less painful for teens
Symptom relief Recruiting nowThis study tests a new 3D-printed scoliosis brace that has flexible sections to improve comfort. Five teens aged 8-18 who already wear a standard brace will try the new brace and compare how it feels during everyday tasks like sitting and putting on shoes. The goal is to see if a…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New brain zapping combo aims to calm Alzheimer's agitation
Symptom relief Recruiting nowThis pilot study tests a combination of two non-invasive brain stimulation methods (iTBS and tDCS) in 20 veterans with mild-to-moderate Alzheimer's disease who also have mood swings, apathy, or agitation. Participants will receive one week of in-clinic iTBS sessions followed by f…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Ear zaps may boost brain power in veterans with TBI
Symptom relief Recruiting nowThis study tests a non-invasive device that sends mild electrical pulses to the ear to stimulate the vagus nerve. Researchers want to see if it can improve attention and memory in 30 veterans with traumatic brain injury, depression, or PTSD. Participants will try both the real st…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Can helping with food and stress improve kids' development?
Symptom relief Recruiting nowThis study aims to help families with food insecurity and mothers with depression by providing resources like food, rent help, and mental health support. Researchers will enroll 2,000 caregivers of young children in the hospital to see if these services improve mother-child bondi…
Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
New coaching program aims to boost quality of life for ovarian cancer survivors
Symptom relief Recruiting nowThis study tests a coaching program called POSTCARE-O for women with ovarian cancer who have finished their initial treatment. The program provides support during the transition to survivorship, focusing on quality of life and emotional well-being. 120 women will be randomly assi…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Gadget may make colon surgery faster and safer
Symptom relief Recruiting nowThis study compares two ways to remove abnormal growths from the colon: using a special traction device versus the standard method. The goal is to see if the device makes the procedure faster and reduces complications. About 150 adults with certain types of colon growths will tak…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New bipolar knife could make esophageal surgery safer
Symptom relief Recruiting nowThis study tests a new device called the Speedboat™ Ultraslim, a bipolar radiofrequency knife, for removing precancerous growths in the esophagus. Researchers want to see if it works well and is safe compared to standard tools. The trial will involve 50 adults at two medical cent…
Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Simple video could curb antibiotic overuse for UTIs
Symptom relief Recruiting nowThis study tests whether a short animated video and flyer, available in English and Spanish, can help patients collect cleaner urine samples. Contaminated samples often lead to wrong diagnoses and unnecessary antibiotics, which fuels antibiotic resistance. About 252 adults in pri…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Can a 2-Day therapy session help veterans with PTSD?
Symptom relief Recruiting nowThis study is testing two different ways of delivering intensive cognitive behavioral therapy (CBT) to veterans with PTSD and anxiety disorders. One format is individual therapy over two weeks, and the other is group therapy over two days. Both are compared to standard care. The …
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Magic mushroom therapy for veterans: a new hope for PTSD?
Symptom relief Recruiting nowThis study tests whether a guided therapy using psilocybin (the active ingredient in magic mushrooms) can safely help US Veterans with PTSD. Fifteen participants will receive two psilocybin sessions combined with talk therapy. The goal is to reduce PTSD symptoms and improve long-…
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Could bright glasses beat brain fog? new study tests light therapy in young cancer survivors
Symptom relief Recruiting nowThis study tests whether wearing special glasses that emit bright light can help reduce fatigue and improve thinking speed and attention in children and teens who have been treated for a brain tumor. The study will include 40 survivors and compare the bright light glasses to dim …
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 26, 2026 18:09 UTC
-
Scientists hunt for clues to rare genetic disorders
Knowledge-focused Recruiting nowThis observational study aims to find biological markers (biomarkers) for RAI1-related disorders, including Smith-Magenis and Potocki-Lupski syndromes. Researchers will study 90 participants through clinical exams, blood tests, optional skin biopsies, and sleep studies. The goal …
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Screen time before bed: does it really ruin Kids' sleep?
Knowledge-focused Recruiting nowThis study aims to understand how the light from tablet screens and the type of content children watch before bed affect their sleep, thinking skills, and emotions. Researchers will have 220 children aged 8 to 11 spend one hour before bed either using a bright tablet, a dim table…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Scientists infect volunteers with hookworms to test future vaccine
Knowledge-focused Recruiting nowThis study aims to find the safest and most consistent dose of hookworm larvae to use in future vaccine trials. Healthy adults aged 18 to 45 will receive different numbers of hookworm larvae through the skin. Researchers will monitor side effects and measure hookworm eggs in stoo…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
500 kids with severe obesity to help unlock genetic secrets
Knowledge-focused Recruiting nowThis study collects data from 500 children with severe, early-onset obesity to find genetic causes. Researchers will track how many kids have genetic variants linked to obesity and monitor changes in their BMI over time. The goal is to better understand the role of genetics in se…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Massive study seeks clues to rare eye disorders in kids
Knowledge-focused Recruiting nowThis research study aims to learn more about children born with small or missing eyes (Microphthalmia, Anophthalmia, and Coloboma, or MAC) and how genetic changes may cause these conditions. Researchers will collect medical histories, saliva, and blood samples, and perform physic…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Scientists hunt for the gene behind rare brain disorder
Knowledge-focused Recruiting nowThis study aims to find the specific gene that causes Aicardi syndrome, a rare brain disorder. Researchers will collect blood and skin samples from up to 500 patients and their parents to analyze their DNA. The goal is to identify genetic changes unique to people with Aicardi syn…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Baby food breakthrough: can carrots boost your Child's eyesight?
Knowledge-focused Recruiting nowThis study looks at how healthy substances called carotenoids (found in colorful fruits and vegetables) affect vision and skin in infants and toddlers. Researchers will track 208 healthy children from 4 to 24 months old, measuring their diet, skin carotenoid levels, and eyesight.…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New Bandage-Sized sensor could replace bulky scans for hydrocephalus monitoring
Knowledge-focused Recruiting nowThis study tests a new wireless sensor called FlowSense, which is placed on the skin like a bandage to measure fluid flow in hydrocephalus patients with external drains. The goal is to see if it can accurately track drainage and pressure without needing X-rays or hospital equipme…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Scientists use brain implants and AI to decode mood
Knowledge-focused Recruiting nowThis study aims to better understand how brain activity relates to mood in people with depression or epilepsy. Researchers will record brain signals directly from electrodes placed inside the skull while participants complete mood assessments and tasks. The goal is to use explain…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Twin surgery study: which entry method is safer?
Knowledge-focused Recruiting nowThis study looks at two common techniques surgeons use to enter the uterus during laser surgery for twin-to-twin transfusion syndrome. The goal is to see if one method causes less separation of the membrane around the baby. About 216 pregnant women with this condition will take p…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Can a simple nutrient help teens with diabetes?
Knowledge-focused Recruiting nowThis study looks at how the body processes arginine, a natural nutrient, in teenagers with type 2 diabetes. Researchers will give participants arginine and measure its effect on insulin production. The goal is to better understand the disease and see if arginine could be a safe, …
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Scientists probe Brain's social wiring to tackle depression
Knowledge-focused Recruiting nowThis study aims to understand how the brain processes social and emotional information in people with treatment-resistant depression or epilepsy. Researchers will use special electrodes placed inside the brain to record activity while participants perform mood-related tasks. The …
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Could a Baby's genes cause HIE? new study investigates
Knowledge-focused Recruiting nowThis study offers genome sequencing to 25 newborns diagnosed with HIE (a severe brain condition from lack of oxygen at birth) who are receiving cooling therapy. Researchers want to find out how often genetic changes cause or contribute to HIE. The goal is to help doctors decide w…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Scientists launch major study to unravel rare genetic disorder
Knowledge-focused Recruiting nowThis study aims to collect medical information and biological samples from 300 people with TANGO2-related disorder, a rare genetic condition. By tracking health events like metabolic and cardiac crises over time, researchers hope to better understand the disease course. The goal …
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Can a sedative help kids need less anesthesia?
Knowledge-focused Recruiting nowThis study looks at whether giving children a sedative called dexmedetomidine (Precedex) can lower the amount of sevoflurane anesthesia needed during surgery. Researchers will test two different doses in 180 children aged 1 month to 3 years. The goal is to find the right balance …
Phase: PHASE4 • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC